LEO Pharma announces U.S. approval of Enstilar foam for plaque psoriasis

19 October 2015 - Enstilar is the first fixed combination foam approved for the treatment of psoriasis vulgaris.

For more details, go to: http://www.leo-pharma.com/Home/LEO-Pharma/Media-Centre/News/News-2015/LEO-Pharma-announces-U.S.-approval-of-Enstilar®-Foam-for-plaque-psoriasis.aspx 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Combination product , US